Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bønaa KH[au]:

Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. Bønaa KH et al. N Engl J Med. (2016)

B Vitamins and Hip Fracture: Secondary Analyses and Extended Follow-Up of Two Large Randomized Controlled Trials. Garcia Lopez M et al. J Bone Miner Res. (2017)

Coronary angiography in non-ST-elevation acute myocardial infarction - whom and when? Bønaa KH et al. Tidsskr Nor Laegeforen. (2017)

Search results

Items: 1 to 50 of 109

1.

Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials.

Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, Kaiser C, Remkes W, Räber L, de Belder A, van 't Hof AWJ, Stankovic G, Lemos PA, Wilsgaard T, Reifart J, Rodriguez AE, Ribeiro EE, Serruys PWJC, Abizaid A, Sabaté M, Byrne RA, de la Torre Hernandez JM, Wijns W, Jüni P, Windecker S, Valgimigli M; Coronary Stent Trialists' Collaboration.

Lancet. 2019 Jun 22;393(10190):2503-2510. doi: 10.1016/S0140-6736(19)30474-X. Epub 2019 May 2. Erratum in: Lancet. 2019 Jun 22;393(10190):2492.

PMID:
31056295
2.

Elevated plasma cystathionine is associated with increased risk of mortality among patients with suspected or established coronary heart disease.

Dhar I, Lysne V, Svingen GFT, Ueland PM, Gregory JF, Bønaa KH, Nygård OK.

Am J Clin Nutr. 2019 Jun 1;109(6):1546-1554. doi: 10.1093/ajcn/nqy391.

PMID:
31005968
3.

Completeness and correctness of acute myocardial infarction diagnoses in a medical quality register and an administrative health register.

Govatsmark RES, Janszky I, Slørdahl SA, Ebbing M, Wiseth R, Grenne B, Vesterbekkmo E, Bønaa KH.

Scand J Public Health. 2018 Sep 29:1403494818803256. doi: 10.1177/1403494818803256. [Epub ahead of print]

PMID:
30269654
4.

Cardiac rehabilitation and symptoms of anxiety and depression after percutaneous coronary intervention.

Olsen SJ, Schirmer H, Wilsgaard T, Bønaa KH, Hanssen TA.

Eur J Prev Cardiol. 2018 Jul;25(10):1017-1025. doi: 10.1177/2047487318778088. Epub 2018 May 30.

PMID:
29846117
5.

Plasma cystathionine and risk of acute myocardial infarction among patients with coronary heart disease: Results from two independent cohorts.

Dhar I, Svingen GFT, Pedersen ER, DeRatt B, Ulvik A, Strand E, Ueland PM, Bønaa KH, Gregory JF, Nygård OK.

Int J Cardiol. 2018 Sep 1;266:24-30. doi: 10.1016/j.ijcard.2018.04.083. Epub 2018 Apr 21.

6.

Plasma Concentrations and Dietary Intakes of Choline and Betaine in Association With Atrial Fibrillation Risk: Results From 3 Prospective Cohorts With Different Health Profiles.

Zuo H, Svingen GFT, Tell GS, Ueland PM, Vollset SE, Pedersen ER, Ulvik A, Meyer K, Nordrehaug JE, Nilsen DWT, Bønaa KH, Nygård O.

J Am Heart Assoc. 2018 Apr 12;7(8). pii: e008190. doi: 10.1161/JAHA.117.008190.

7.

[No title available]

Bønaa KH, Steigen T.

Tidsskr Nor Laegeforen. 2018 Jan 22;138(2). doi: 10.4045/tidsskr.18.0004. Print 2018 Jan 23. Norwegian. No abstract available.

PMID:
29357628
Free Article
8.

Coronary angiography in non-ST-elevation acute myocardial infarction - whom and when?

Bønaa KH, Steigen T.

Tidsskr Nor Laegeforen. 2017 Nov 13;137(22). doi: 10.4045/tidsskr.17.0492. Print 2017 Nov 28. English, Norwegian. No abstract available.

9.

Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.

Bjørnestad EØ, Borsholm RA, Svingen GFT, Pedersen ER, Seifert R, Midttun Ø, Ueland PM, Tell GS, Bønaa KH, Nygård O.

J Am Heart Assoc. 2017 Nov 2;6(11). pii: e006500. doi: 10.1161/JAHA.117.006500.

10.

Cardiac rehabilitation after percutaneous coronary intervention: Results from a nationwide survey.

Olsen SJ, Schirmer H, Bønaa KH, Hanssen TA.

Eur J Cardiovasc Nurs. 2018 Mar;17(3):273-279. doi: 10.1177/1474515117737766. Epub 2017 Oct 19.

PMID:
29048205
11.

Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905-1977 in the population-based Tromsø Study 1979-2016.

Hopstock LA, Bønaa KH, Eggen AE, Grimsgaard S, Jacobsen BK, Løchen ML, Mathiesen EB, Njølstad I, Wilsgaard T.

BMJ Open. 2017 Aug 21;7(8):e015001. doi: 10.1136/bmjopen-2016-015001.

12.

Potential Implications of NORSTENT (Norwegian Coronary Stent Trial) in Contemporary Practice.

Wiseth R, Bønaa KH.

Circulation. 2017 Aug 22;136(8):701-703. doi: 10.1161/CIRCULATIONAHA.116.025946. No abstract available.

PMID:
28827218
13.

Data on gender contrasts in the risk of incident myocardial infarction by age. The Tromsø Study 1979-2012.

Albrektsen G, Heuch I, Løchen ML, Thelle DS, Wilsgaard T, Njølstad I, Bønaa KH.

Data Brief. 2017 Jul 8;13:779-784. doi: 10.1016/j.dib.2017.07.001. eCollection 2017 Aug.

14.

B Vitamins and Hip Fracture: Secondary Analyses and Extended Follow-Up of Two Large Randomized Controlled Trials.

Garcia Lopez M, Bønaa KH, Ebbing M, Eriksen EF, Gjesdal CG, Nygård O, Tell GS, Ueland PM, Meyer HE.

J Bone Miner Res. 2017 Oct;32(10):1981-1989. doi: 10.1002/jbmr.3189. Epub 2017 Jun 28.

15.

Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromsø Study 1979-2012.

Albrektsen G, Heuch I, Løchen ML, Thelle DS, Wilsgaard T, Njølstad I, Bønaa KH.

Atherosclerosis. 2017 Jun;261:52-59. doi: 10.1016/j.atherosclerosis.2017.04.009. Epub 2017 Apr 9.

PMID:
28448842
16.

Body Iron Stores and the Gender Gap in Risk of Incident Myocardial Infarction-Reply.

Albrektsen G, Bønaa KH.

JAMA Intern Med. 2017 Apr 1;177(4):595-596. doi: 10.1001/jamainternmed.2016.9675. No abstract available.

PMID:
28384768
17.

Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.

Nordrehaug JE, Wiseth R, Bønaa KH.

N Engl J Med. 2016 Dec 29;375(26):2604-2605. doi: 10.1056/NEJMc1613866. No abstract available.

PMID:
28029911
18.

Percutaneous Coronary Intervention as a Trigger for Stroke.

Varmdal T, Janszky I, Bakken IJ, Ellekjær H, Fjærtoft H, Håberg SE, Bønaa KH.

Am J Cardiol. 2017 Jan 1;119(1):35-39. doi: 10.1016/j.amjcard.2016.09.012. Epub 2016 Sep 29.

PMID:
27776798
19.

Lifelong Gender Gap in Risk of Incident Myocardial Infarction: The Tromsø Study.

Albrektsen G, Heuch I, Løchen ML, Thelle DS, Wilsgaard T, Njølstad I, Bønaa KH.

JAMA Intern Med. 2016 Nov 1;176(11):1673-1679. doi: 10.1001/jamainternmed.2016.5451.

PMID:
27617629
20.

Interrater reliability of a national acute myocardial infarction register.

Govatsmark RE, Sneeggen S, Karlsaune H, Slørdahl SA, Bønaa KH.

Clin Epidemiol. 2016 Aug 17;8:305-12. doi: 10.2147/CLEP.S105933. eCollection 2016.

21.

Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.

Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygård O, Nilsen DW, Kløw NE, Uchto M, Trovik T, Bendz B, Stavnes S, Bjørnerheim R, Larsen AI, Slette M, Steigen T, Jakobsen OJ, Bleie Ø, Fossum E, Hanssen TA, Dahl-Eriksen Ø, Njølstad I, Rasmussen K, Wilsgaard T, Nordrehaug JE; NORSTENT Investigators.

N Engl J Med. 2016 Sep 29;375(13):1242-52. doi: 10.1056/NEJMoa1607991. Epub 2016 Aug 29.

22.

Validation of self-reported and hospital-diagnosed atrial fibrillation: the HUNT study.

Malmo V, Langhammer A, Bønaa KH, Loennechen JP, Ellekjaer H.

Clin Epidemiol. 2016 Jun 11;8:185-93. doi: 10.2147/CLEP.S103346. eCollection 2016.

23.

Comparison of the validity of stroke diagnoses in a medical quality register and an administrative health register.

Varmdal T, Bakken IJ, Janszky I, Wethal T, Ellekjær H, Rohweder G, Fjærtoft H, Ebbing M, Bønaa KH.

Scand J Public Health. 2016 Mar;44(2):143-9. doi: 10.1177/1403494815621641. Epub 2015 Dec 11.

PMID:
26660300
24.

Trends in Modifiable Risk Factors Are Associated With Declining Incidence of Hospitalized and Nonhospitalized Acute Coronary Heart Disease in a Population.

Mannsverk J, Wilsgaard T, Mathiesen EB, Løchen ML, Rasmussen K, Thelle DS, Njølstad I, Hopstock LA, Bønaa KH.

Circulation. 2016 Jan 5;133(1):74-81. doi: 10.1161/CIRCULATIONAHA.115.016960. Epub 2015 Nov 18.

PMID:
26582781
25.

Inter-rater reliability of a national acute stroke register.

Varmdal T, Ellekjær H, Fjærtoft H, Indredavik B, Lydersen S, Bonaa KH.

BMC Res Notes. 2015 Oct 19;8:584. doi: 10.1186/s13104-015-1556-3.

26.

Longitudinal and Secular Trends in Blood Pressure Among Women and Men in Birth Cohorts Born Between 1905 and 1977: The Tromsø Study 1979 to 2008.

Hopstock LA, Bønaa KH, Eggen AE, Grimsgaard S, Jacobsen BK, Løchen ML, Mathiesen EB, Njølstad I, Wilsgaard T.

Hypertension. 2015 Sep;66(3):496-501. doi: 10.1161/HYPERTENSIONAHA.115.05925. Epub 2015 Jul 20.

PMID:
26195482
27.

Cardiovascular health and the modifiable burden of incident myocardial infarction: the Tromsø Study.

Wilsgaard T, Loehr LR, Mathiesen EB, Løchen ML, Bønaa KH, Njølstad I, Heiss G.

BMC Public Health. 2015 Mar 6;15:221. doi: 10.1186/s12889-015-1573-0.

28.

Clinically significant novel biomarkers for prediction of first ever myocardial infarction: the Tromsø Study.

Wilsgaard T, Mathiesen EB, Patwardhan A, Rowe MW, Schirmer H, Løchen ML, Sudduth-Klinger J, Hamren S, Bønaa KH, Njølstad I.

Circ Cardiovasc Genet. 2015 Apr;8(2):363-71. doi: 10.1161/CIRCGENETICS.113.000630. Epub 2015 Jan 22.

PMID:
25613532
29.

Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease.

Svingen GF, Schartum-Hansen H, Ueland PM, Pedersen ER, Seifert R, Ebbing M, Bønaa KH, Mellgren G, Nilsen DW, Nordrehaug JE, Øyen J, Nygård O.

Eur J Prev Cardiol. 2015 Jun;22(6):743-52. doi: 10.1177/2047487314529351. Epub 2014 Mar 26.

PMID:
24671904
30.

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals.

Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, Armitage J, Manson JE, Hankey GJ, Spence JD, Galan P, Bønaa KH, Jamison R, Gaziano JM, Guarino P, Baron JA, Logan RF, Giovannucci EL, den Heijer M, Ueland PM, Bennett D, Collins R, Peto R; B-Vitamin Treatment Trialists' Collaboration.

Lancet. 2013 Mar 23;381(9871):1029-36.

31.

Seasonal variation in cardiovascular disease risk factors in a subarctic population: the Tromsø Study 1979-2008.

Hopstock LA, Barnett AG, Bønaa KH, Mannsverk J, Njølstad I, Wilsgaard T.

J Epidemiol Community Health. 2013 Feb;67(2):113-8. doi: 10.1136/jech-2012-201547. Epub 2012 Aug 2.

PMID:
22859515
32.

Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromso Study.

Mannsverk J, Wilsgaard T, Njølstad I, Hopstock LA, Løchen ML, Mathiesen EB, Thelle DS, Rasmussen K, Bønaa KH.

Eur J Prev Cardiol. 2012 Oct;19(5):927-34. doi: 10.1177/1741826711421081. Epub 2011 Aug 22.

PMID:
21859780
33.

The effect of daily weather conditions on myocardial infarction incidence in a subarctic population: the Tromsø Study 1974-2004.

Hopstock LA, Fors AS, Bønaa KH, Mannsverk J, Njølstad I, Wilsgaard T.

J Epidemiol Community Health. 2012 Sep;66(9):815-20. doi: 10.1136/jech.2010.131458. Epub 2011 Jun 6.

PMID:
21652517
34.

Determinants of cardiac vagal regulation: a cross-sectional study in a general population.

Berntsen RF, Bønaa KH, Huikuri HV, Rasmussen K.

Auton Neurosci. 2011 Jul 5;162(1-2):54-9. doi: 10.1016/j.autneu.2011.03.005. Epub 2011 Apr 20.

PMID:
21511544
35.

Myocardial infarction mortality.

Bønaa KH.

Tidsskr Nor Laegeforen. 2011 Mar 4;131(5):440-1. doi: 10.4045/tidsskr.11.0081. English, Norwegian. No abstract available.

36.

Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromsø Study.

Mathiesen EB, Johnsen SH, Wilsgaard T, Bønaa KH, Løchen ML, Njølstad I.

Stroke. 2011 Apr;42(4):972-8. doi: 10.1161/STROKEAHA.110.589754. Epub 2011 Feb 10.

PMID:
21311059
37.

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.

Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bønaa KH, Spence JD, Nygård O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R; B-Vitamin Treatment Trialists' Collaboration.

Arch Intern Med. 2010 Oct 11;170(18):1622-31. doi: 10.1001/archinternmed.2010.348. Review.

PMID:
20937919
38.

Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.

Ebbing M, Bønaa KH, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, Njølstad I, Nilsen DW, Refsum H, Tverdal A, Vollset SE, Schirmer H, Bleie Ø, Steigen T, Midttun Ø, Fredriksen A, Pedersen ER, Nygård O.

J Intern Med. 2010 Oct;268(4):367-82. doi: 10.1111/j.1365-2796.2010.02259.x.

39.

Seasonal variation in incidence of acute myocardial infarction in a sub-Arctic population: the Tromsø Study 1974-2004.

Hopstock LA, Wilsgaard T, Njølstad I, Mannsverk J, Mathiesen EB, Løchen ML, Bønaa KH.

Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):320-5. doi: 10.1097/HJR.0b013e32833c7c28.

PMID:
20606596
40.

Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.

Collin SM, Metcalfe C, Refsum H, Lewis SJ, Zuccolo L, Smith GD, Chen L, Harris R, Davis M, Marsden G, Johnston C, Lane JA, Ebbing M, Bønaa KH, Nygård O, Ueland PM, Grau MV, Baron JA, Donovan JL, Neal DE, Hamdy FC, Smith AD, Martin RM.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1632-42. doi: 10.1158/1055-9965.EPI-10-0180. Epub 2010 May 25. Review.

41.

Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins.

Ulvik A, Ebbing M, Hustad S, Midttun Ø, Nygård O, Vollset SE, Bønaa KH, Nordrehaug JE, Nilsen DW, Schirmer H, Ueland PM.

Clin Chem. 2010 May;56(5):755-63. doi: 10.1373/clinchem.2009.137513. Epub 2010 Mar 18.

42.

Cancer incidence and mortality after treatment with folic acid and vitamin B12.

Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, Njølstad I, Refsum H, Nilsen DW, Tverdal A, Meyer K, Vollset SE.

JAMA. 2009 Nov 18;302(19):2119-26. doi: 10.1001/jama.2009.1622.

PMID:
19920236
43.

Low testosterone levels are associated with carotid atherosclerosis in men.

Svartberg J, von Mühlen D, Mathiesen E, Joakimsen O, Bønaa KH, Stensland-Bugge E.

J Intern Med. 2006 Jun;259(6):576-82.

44.

Homocysteine lowering and cardiovascular events after acute myocardial infarction.

Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators.

N Engl J Med. 2006 Apr 13;354(15):1578-88. Epub 2006 Mar 12.

45.

Coronary stents reduce restenosis and repeat revascularizations and may also improve survival.

Vik-Mo H, Bønaa KH.

Scand Cardiovasc J. 2004 Aug;38(4):195-6. No abstract available.

PMID:
15553928
46.

Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study.

Brodin E, Børvik T, Sandset PM, Bønaa KH, Nordøy A, Hansen JB.

Thromb Haemost. 2004 Jul;92(1):178-84.

PMID:
15213859
47.

Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromsø Study.

Mathiesen EB, Waterloo K, Joakimsen O, Bakke SJ, Jacobsen EA, Bønaa KH.

Neurology. 2004 Mar 9;62(5):695-701.

PMID:
15007116
48.

The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study.

Svartberg J, Midtby M, Bønaa KH, Sundsfjord J, Joakimsen RM, Jorde R.

Eur J Endocrinol. 2003 Aug;149(2):145-52.

PMID:
12887292
49.

Seasonal variation of testosterone and waist to hip ratio in men: the Tromsø study.

Svartberg J, Jorde R, Sundsfjord J, Bønaa KH, Barrett-Connor E.

J Clin Endocrinol Metab. 2003 Jul;88(7):3099-104.

PMID:
12843149
50.

Quantitative measurement of muscle fiber composition in a normal population.

Toft I, Lindal S, Bønaa KH, Jenssen T.

Muscle Nerve. 2003 Jul;28(1):101-8.

PMID:
12811780

Supplemental Content

Loading ...
Support Center